UFCM - I Care ceases operations
At its general assembly on February 18, 2023, the UFCM-i Care association unanimously decided, by the votes represented, to finalize the closure of the association's activities.
Since 2012, UFCM-I Care has been raising public, healthcare professional, and political community awareness about the need to legalize medical cannabis in France.
The association's objectives included informing and combating stigmatization, guiding patients and healthcare professionals, and supporting and defending patients' rights and interests.
Each year, UFMC-I Care organized an international symposium on pharmacological advances and therapeutic uses of cannabinoids, generally in Strasbourg but in Paris in 2018, which brought together between 200 and 300 people. Renowned panelists came to these conferences: Raphaël Mechoulam, Franjo Grotenhermen, Ethan Russo or Raquel Peyraube.
From its creation, patients took the lead of the association and had set a goal to stop once healthcare professionals and the medical production sector took the front line.
«This is what is happening to this day and this is what we are doing, perhaps a little more radically than planned, but the context is there,» explains the press release.
In the press release, the association's board members thank «all those who ensured the success of its activity as well as our financial partnersSensi Seeds, Storz & Bickel, Aurora, Solanaceae editions...).»
UFCM - I Care conferences remain available on YouTube.
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Business2 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login